Table 2.
Demographic and clinical characteristics of HIV-1-infected
| Parameters | All population | Female | Male | pvalue | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean ± SD | Median with IQR | n(n%) | Mean ± SD | Median with IQR | n(n%) | Mean ± SD | Median with IQR | n(n%) | ||
| Age (years) | 45 ± 8 | 47(44–52) | - | 49 ± 5 | 51(45–52) | - | 43 ± 9 | 46 (37–48) | - | 0.067 |
| Gender (female) | - | - | 15 (50) | - | - | - | - | - | - | - |
| Smokers | - | - | 17 (57) | - | - | 6 (40) | - | - | 11 (73) | 0.762 |
| BMI (Kg/m2) | 23 ± 3 | 23 (21–25) | 22 ± 4 | 21(19–24) | 23 ± 2 | 24(22–25) | - | 0.373 | ||
| Race (Caucasian) | - | - | 29 (97) | - | 14 (93) | - | - | 15 (100) | 0.987 | |
| Years on ART (years) | 12 ± 9 | 11 (5–19) | - | 17 ± 6 | 15(11–22) | - | 9 ± 9 | 5(1–15) | - | 0.012 |
| Years HIV diagnosis (years) | 12 ± 9 | 11(5–19) | - | 17 ± 6 | 15(11–22) | - | 9 ± 9 | 5(1–15) | - | 0.014 |
| CD4+ actual (cells/mm3) | 744 ± 299 | 708 (623–886) | - | 790 ± 275 | 789 (692–886) | - | 718 ± 317 | 667 (623–825) | - | 0.560 |
| CD4+ (%) | 33 ± 11 | 34 (30–38) | - | 38 ± 5 | 36 (30–38) | - | 30 ± 12 | 32 (24–37) | - | 0.032 |
| CD4+ nadir (cells/mm3) | 283 ± 223 | 301 (74–382) | - | 182 ± 144 | 163 (74–278) | - | 321 ± 239 | 322 (109–522) | 0.117 | |
| HCV infection | - | - | 3 (10) | - | - | 1 (7) | - | - | 2 (13) | 0.922 |
| HIV-RNA actual (copies/mL) | < 37 | - | - | < 37 | - | - | <37 | - | - | 1.000 |
SD standard deviation, BMI body mass index, ART antiretroviral therapy